3-[(6-Hydroxyhexyl)oxyiminomethyl]rifamycin SV(52370-33-9)
- Name: 3-[(6-Hydroxyhexyl)oxyiminomethyl]rifamycin SV
- Synonyms:2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione,3-formyl-5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-,21-acetate,O-(6-hydroxyhexyl)oxime;3-Formylrifamycin SV O-(6-hydroxyhexyl)oxime;
- Molecular Formula:C44H60N2O14
- Molecular Weight:840.9522
- CAS Registry Number:52370-33-9
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.52370-33-9 Rifamycin,3-[[[(6-hydroxyhexyl)oxy]imino]- methyl]-
Assay:99% Appearance:White powder Package:25KGS/Drum Storage:Room temperature Transportation:BY SEA Application:API锛孭harmaceutical intermediates
Min. Order:1Gram
Supplier:HENAN NEW BLUE CHEMICAL CO.,LTD [
China (Mainland)] CAS No.52370-33-9 3-[(6-Hydroxyhexyl)oxyiminomethyl]rifamycin SV
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
Other Product
- 7385-78-6/3,4-DIMETHYL-1-PENTENE
- 16555-77-4/ALPHA-HYDROXYHIPPURIC ACID
- 2143-59-1/cyclohexyldioxidanyl
- 100632-37-9/(3E,5E,11E,13E)-16-[(5E)-2,8-dihydroxy-1,3,7-trimethyl-4-oxonon-5-en-1-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyloxacyclohexadeca-3,5,11,13-tetraen-2-one
- 56939-52-7/4H-1-Benzopyran-4-one,3-[[6-deoxy-2-O- (3,4,5-trihydroxybenzoyl)-R-Lmannopyranosyl] oxy]-5,7-dihydroxy-2-(3,4,5- trihydroxyphenyl)-
- 150840-31-6/11-{[(3beta)-3-hydroxy-28-oxolup-20(29)-en-28-yl]amino}undecanoic acid
- 57556-11-3/3(2H)-Selenophenone, 2,2,5-trimethyl-
- 145144-32-7/Butyrolactol A
- 13010-47-4/Lomustine
- 65776-67-2/Afurolol
- 91403-60-0/2-Pyridineacetic acid,3-[3-(carboxymethyl)-4,- 5-dihydro-4,5-dioxo-1H-pyrrol-2-yl]-1,6- dihydro-4,5-dihydroxy-6-oxo-
- 19167-60-3/pteridine-4,6-diamine
- 62951-75-1/4H-Dibenzo[de,g]quinoline-2,7-diol,5,6,6a,7- tetrahydro-1-methoxy-6-methyl-,(6aS,7S)-
- 115160-07-1/naltrexone phenyl oxime
- 69847-99-0/Phosphorothioic acid,esters,S-[2-(ethylsulfinyl)- ethyl] O,O-dimethyl ester,mixt. with 4-chloro-R-(4-chlorophenyl)-R-(trichloromethyl) benzenemethanol and 1-naphthalenyl methylcarbamate
- 17066-43-2/1,7,7-trimethyl-3-(piperidin-1-ylmethyl)bicyclo[2.2.1]hept-2-yl 4-aminobenzoate
- 51115-76-5/N-(2-hydroxy-1,1-dimethylethyl)-2-isopropyl-2,3-dimethylbutyramide
- 18309-28-9/(2S-cis)-2-(isopropyl)-5-methylcyclohexan-1-one
- 68987-29-1/1-Octadecanol, phosphate, potassium salt
- 52370-33-9/3-[(6-Hydroxyhexyl)oxyiminomethyl]rifamycin SV
- 65284-03-9/15-Des-trp-phe-gramicidin A
- 85203-99-2/1-Propanesulfonic acid, 2-hydroxy-3-((2-hydroxyethyl)amino)-, N-(beta-hydroxy-C12-14-alkyl) derivs., monosodium salts
- 64203-02-7/2-chloro-N-(2-methoxyethyl)-N-(4-methoxyphenyl)acetamide
- 6997-59-7/2-methylpropyl 2-{[4-(acetyloxy)-3-methoxyphenyl]methylidene}-5-[4-(methoxycarbonyl)phenyl]-7-methyl-3-oxo-2,3-dihydro-5H-[1,3]thiazolo[3,2-a]pyrimidine-6-carboxylate
- 35633-73-9/N-{1-[2-(2-methyl-1H-indol-3-yl)ethyl]-1,2,3,6-tetrahydropyridin-4-yl}acetamide
- 41642-52-8/4,4'-[2,4,6-Trimethyl-1,3-phenylenebis(methylene)]bis[2,6-di(tert-butyl)phenol]
- 83387-25-1/methylnaltrexone
- 4623-91-0/5-[[4'-[[8-[(2,4-Diaminophenyl)azo]-1-hydroxy-3,6-disulfo-2-naphtyl]azo]-1,1'-biphenyl-4-yl]azo]-2-hydroxybenzoic acid trisodium salt
- 115910-09-3/pindolol-NBD
- 55348-40-8/Poly(oxy-1,2-ethanediyl), .alpha.-sulfo-.omega.-(1,1,3,3-tetramethylbutyl)phenoxy-, sodium salt